-
Indianapolis-based Eli Lilly is joining other pharmaceutical companies in arguing against legislation that aims to reduce drug costs. Congress is debating…
-
Diabetes advocates say Eli Lilly’s latest price reduction on one of its generic insulins is not enough. One group says the cost of insulin is still…
-
Indianapolis-based pharmaceutical company Eli Lilly is reducing the list price of one of its frequently-used insulins for a second time in the last two…
-
Global pharmaceutical company Eli Lilly is planning for employees working from home to return to their Indianapolis offices this summer. Officials say…
-
Eli Lilly is joining other pharmaceutical companies working to fight the surge of COVID-19 cases in India. The country has reported almost 4,000 deaths…
-
INDIANAPOLIS (AP) — One of Indiana’s most prominent corporations is criticizing an Indiana proposal that opponents maintain will make mail-in voting more…
-
Indianapolis-based Eli Lilly is partnering with health care systems around the state to increase access and affordability around its COVID-19 antibody…
-
INDIANAPOLIS (AP) — Drugmaker Eli Lilly says its COVID-19 antibody drug can prevent illness among residents and staff of nursing homes and other long-term…
-
The Food and Drug Administration (FDA) has given emergency authorization to Eli Lilly for its COVID-19 antibody drug bamlanivimab.The Indianapolis-based…
-
Eli Lilly paused trials of its COVID-19 treatment drug Tuesday. The news came less than a day after Johnson & Johnson also paused its trial on a COVID-19…